Bio-Techne Corp

NAS:TECHHealthcareCBOE:SPESGSTOXX:EDD24BP

$72.49−0.11%At closeAt close · Tue 20 Oct · ≈ AED 266.22 · Market cap $11.37B · Next earnings Tue 3 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	68.0%	68.4%	67.7%	66.4%	64.8%	65.8%	—	—
Operating margin	25.5%	26.8%	26.3%	17.8%	8.4%	20.7%	8.4%	−12.3 pts
Net margin	15.1%	24.6%	25.1%	14.5%	6.0%	15.0%	6.0%	−8.9 pts
EBITDA margin	26.8%	37.4%	40.2%	27.0%	17.8%	28.7%	—	—
Return on equity	9.0%	16.0%	14.5%	8.1%	3.8%	8.6%	3.8%	−4.8 pts
Return on assets	6.2%	11.9%	10.8%	6.2%	2.9%	7.0%	2.9%	−4.2 pts
Return on capital employed	11.2%	14.0%	11.9%	8.1%	4.3%	10.4%	—	—
Debt / equity	0.3×	0.2×	0.2×	0.2×	0.2×	0.1×	0.2×	+68.8%
Debt / assets	18.6%	14.2%	17.2%	15.5%	17.4%	11.2%	—	—
Interest coverage	17.0×	26.2×	26.7×	13.1×	12.0×	26.2×	—	—
Current ratio	3.4×	3.4×	4.8×	3.9×	3.5×	4.5×	3.5×	−23.9%
Quick ratio	2.6×	2.6×	3.5×	2.7×	2.4×	3.4×	—	—
Cash ratio	1.3×	1.0×	1.4×	1.0×	0.9×	1.6×	0.9×	−43.0%
Asset turnover	0.4×	0.5×	0.4×	0.4×	0.5×	0.5×	—	—
Inventory turnover	2.6×	2.5×	2.1×	2.2×	2.3×	2.1×	—	—
Receivables turnover	6.4×	5.7×	5.2×	4.8×	5.9×	5.6×	—	—
Dividend payout	35.3%	18.4%	17.6%	30.0%	68.7%	27.5%	—	—

Margins, returns, leverage and liquidityUpdated Tue 30 Jun ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.